Karyopharm Therapeutics Inc. buy Rodman & Renshaw
Start price
09.03.26
/
50%
€0.54
Target price
09.03.27
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.03.27. The prediction end date can be changed by Rodman___Renshaw at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Rodman___Renshaw for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (KPTI) is now covered by Rodman & Renshaw. They set a "buy" rating on the stock.
Ratings data for KPTI provided by MarketBeat